Background Pleural effusion is common in routine medical practice and can be due to many
different underlying diseases. Precise differential diagnostic categorization is essential, as …

Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Background: This Guideline, a collaborative effort from the American Thoracic Society,
Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence …

Background Malignant pleural effusion affects more than 750,000 persons each year across
Europe and the United States. Pleurodesis with the administration of talc in hospitalized …

Malignant pleural effusions are common in patients with cancer. Most malignant pleural
effusions are secondary to metastases to the pleura, most often from lung or breast cancer …

Background Indwelling pleural catheters are an established management option for
malignant pleural effusion and have advantages over talc slurry pleurodesis. The optimal …

Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a
common and effective treatment. There are no reliable data, however, regarding the optimal …

Malignant pleural mesothelioma is an aggressive, incurable cancer that is usually caused by
asbestos exposure several decades before symptoms arise. Despite widespread prohibition …

Simple Summary Mesothelioma is a cancer of the lining of the lungs caused by breathing in
asbestos fibres. Asbestos was widely used in industry in the last century in most developed …

Chemical pleurodesis is a therapeutic procedure applied to create the symphysis between
the parietal and visceral pleura by intrapleural administration of various chemical agents (eg …